Brain and spine MRI features of Hunter disease: frequency, natural evolution and response to therapy
- 765 Downloads
Hunter disease is a rare X-linked mucopolysaccharidosis. Despite frequent neurological involvement, characterizing the severe phenotype, neuroimaging studies are scarce.
To determine frequency and severity of neuroradiological mucopolysaccharidosis-related features; to correlate them with clinical phenotype; to evaluate their natural evolution and the impact of intravenous enzymatic replacement therapy (ERT).
Sixty nine brain MRI examinations of 36 Italian patients (mean-age 10.4 years; age-range 2.2-30.8; severe phenotype in 22 patients) were evaluated. Twenty patients had multiple MRIs (median follow-up 3.1 years, range 1–16.9): among them 15 had MRIs before and after ERT, six had repeated MRIs without being on ERT and five while on ERT. Perivascular, subarachnoid and ventricle space enlargement, white matter abnormality (WMA) burden, pituitary sella/skull/posterior fossa abnormalities, periodontoid thickening, spinal stenosis, dens hypoplasia, myelopathy, vertebral and intervertebral disc abnormalities were graded by means of dedicated scales.
Perivascular spaces enlargement (89%), WMAs (97%), subarachnoid space enlargement (83%), IIIrd-ventricle dilatation (100%), pituitary sella abnormalities (80%), cranial hyperostosis (19%), craniosynostosis (19%), enlarged cisterna magna (39%), dens hypoplasia (66%), periodontoid thickening (94%), spinal stenosis (46%), platyspondylia (84%) and disc abnormalities (79%) were frequently detected. WMAs, IIIrd-ventricle dilatation and hyperostosis correlated with the severe phenotype (p < 0.05). Subarachnoid spaces and ventricle enlargement, WMAs and spinal stenosis progressed despite ERT, while other MR features showed minimal or no changes.
The spectrum of brain and spine MRI abnormalities in Hunter disease is extremely wide and requires a thorough evaluation. WMAs, atrophy/communicating hydrocephalus and spinal stenosis progress over time and might represent possible disease severity markers for new treatment efficacy assessment.
KeywordsEnzyme Replacement Therapy Spinal Stenosis Magnetic Resonance Image Examination Magnetic Resonance Image Feature Magnetic Resonance Image Abnormality
We acknowledge Fondazione Pierfranco e Luisa Mariani for their consistent economic support to the metabolic Center in Monza.
We acknowledge Frits Wijburg and Chiara Briani for their critical support.
- Fan Z, Styner M, Muenzer J, Poe M, Escolare M (2010) Correlation of Automated Volumetric Analysis of Brain MR Imaging with Cognitive Impairment in a Natural History Study of Mucopolysaccharidosis II. AJNR Am J Neuroradiol;[Epub ahead of print].Google Scholar
- Fazekas F, Chawluk J, Alavi A, Hurtig H, Zimmerman R (1987) MRI signal abnormalities at 1.5T in Alzheimer’s dementia and normal aging. AJNR Am J Neuroradiol 8:421–426Google Scholar
- Lee C, Dineen TE, Brack M, Kirsch JE, Runge VM (1993) The mucopolysaccharidoses: characterization by cranial MR imaging. Am J Neuroradiol 4:1285–1292Google Scholar
- Stevens JM, Kendall BE, Crockard HA, Ransford A (1991) The odontoid process in Morquio-Brailsford's disease. The effects of occipitocervical fusion. J Bone Jt Surg Br 73(5):851–858Google Scholar